Vivani Medical (VANI) Competitors $1.21 -0.01 (-0.82%) Closing price 04:00 PM EasternExtended Trading$1.23 +0.02 (+1.24%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VANI vs. RXST, NPCE, CATX, CLPT, SKIN, TCMD, DRTS, NNOX, STIM, and SMTIShould you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include RxSight (RXST), NeuroPace (NPCE), Perspective Therapeutics (CATX), ClearPoint Neuro (CLPT), Beauty Health (SKIN), Tactile Systems Technology (TCMD), Alpha Tau Medical (DRTS), Nano-X Imaging (NNOX), Neuronetics (STIM), and Sanara MedTech (SMTI). These companies are all part of the "medical equipment" industry. Vivani Medical vs. Its Competitors RxSight NeuroPace Perspective Therapeutics ClearPoint Neuro Beauty Health Tactile Systems Technology Alpha Tau Medical Nano-X Imaging Neuronetics Sanara MedTech Vivani Medical (NASDAQ:VANI) and RxSight (NASDAQ:RXST) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation. Does the media favor VANI or RXST? In the previous week, RxSight had 30 more articles in the media than Vivani Medical. MarketBeat recorded 36 mentions for RxSight and 6 mentions for Vivani Medical. RxSight's average media sentiment score of 0.00 beat Vivani Medical's score of -0.01 indicating that RxSight is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivani Medical 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral RxSight 0 Very Positive mention(s) 2 Positive mention(s) 28 Neutral mention(s) 4 Negative mention(s) 2 Very Negative mention(s) Neutral Do analysts recommend VANI or RXST? Vivani Medical currently has a consensus price target of $4.00, suggesting a potential upside of 230.58%. RxSight has a consensus price target of $10.00, suggesting a potential upside of 14.55%. Given Vivani Medical's stronger consensus rating and higher possible upside, analysts clearly believe Vivani Medical is more favorable than RxSight.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00RxSight 2 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.91 Which has more volatility & risk, VANI or RXST? Vivani Medical has a beta of 2.99, meaning that its share price is 199% more volatile than the S&P 500. Comparatively, RxSight has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Do institutionals & insiders hold more shares of VANI or RXST? 6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 78.8% of RxSight shares are owned by institutional investors. 46.4% of Vivani Medical shares are owned by company insiders. Comparatively, 9.6% of RxSight shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is VANI or RXST more profitable? Vivani Medical has a net margin of 0.00% compared to RxSight's net margin of -21.93%. RxSight's return on equity of -11.56% beat Vivani Medical's return on equity.Company Net Margins Return on Equity Return on Assets Vivani MedicalN/A -194.66% -68.64% RxSight -21.93%-11.56%-10.31% Which has preferable earnings & valuation, VANI or RXST? Vivani Medical has higher earnings, but lower revenue than RxSight. RxSight is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivani MedicalN/AN/A-$23.49M-$0.45-2.69RxSight$139.93M2.55-$27.45M-$0.80-10.91 SummaryVivani Medical beats RxSight on 8 of the 14 factors compared between the two stocks. Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VANI vs. The Competition Export to ExcelMetricVivani MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.68M$2.49B$5.74B$9.56BDividend YieldN/A1.66%4.53%4.08%P/E Ratio-2.6922.4830.4525.16Price / SalesN/A549.05392.5887.64Price / CashN/A173.7937.0358.50Price / Book15.135.268.956.21Net Income-$23.49M$31.83M$3.26B$265.38M7 Day Performance-4.72%0.83%1.06%-1.13%1 Month Performance-21.94%3.71%4.31%-0.71%1 Year Performance-12.95%9.37%28.40%18.89% Vivani Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VANIVivani Medical2.1955 of 5 stars$1.21-0.8%$4.00+230.6%-11.6%$71.68MN/A-2.6920News CoverageRXSTRxSight1.6849 of 5 stars$7.35+10.5%$10.00+36.1%-84.3%$300.76M$139.93M-9.19220Short Interest ↑Gap DownNPCENeuroPace3.4543 of 5 stars$9.13+2.7%$17.00+86.2%+19.6%$299.46M$79.91M-10.87170Short Interest ↑Analyst RevisionCATXPerspective Therapeutics1.5657 of 5 stars$3.98+7.0%$12.56+215.5%-77.2%$295.43MN/A0.0070Trending NewsAnalyst RevisionCLPTClearPoint Neuro1.7376 of 5 stars$10.54-0.6%$19.67+86.6%-7.9%$295.02M$31.39M-13.87110SKINBeauty Health1.7122 of 5 stars$2.32+5.0%$2.63+13.1%+44.2%$292.30M$334.30M-8.291,030High Trading VolumeTCMDTactile Systems Technology2.713 of 5 stars$12.57+3.3%$13.50+7.4%+0.6%$280.19M$292.98M20.271,037Positive NewsDRTSAlpha Tau Medical2.5648 of 5 stars$3.25-8.7%$8.00+146.2%+40.4%$275.67MN/A-7.0780News CoverageNNOXNano-X Imaging2.3377 of 5 stars$4.45-5.5%$9.50+113.5%-45.3%$257.12M$11.28M-4.94190STIMNeuronetics2.3631 of 5 stars$3.86-1.5%$5.00+29.5%+226.5%$255.22M$74.89M-3.42180SMTISanara MedTech2.2509 of 5 stars$27.47+2.3%$49.50+80.2%-4.7%$244.21M$86.67M-20.5060News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies RXST Competitors NPCE Competitors CATX Competitors CLPT Competitors SKIN Competitors TCMD Competitors DRTS Competitors NNOX Competitors STIM Competitors SMTI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VANI) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access